inovalon revenue 2019

Interest Expense is likely to climb to about 71 M in 2020, whereas Cost of Revenue is likely to drop slightly above 165.9 M in 2020. Inovalon reported $316.4 million in revenue for the first half of 2020, up 5% from $302.5 million for the first half of 2019, according to Securities and Exchange Commission filings. Specifically, in Q3 2020's revenue was $161.4M; in Q2 2020, it was $162.2M; in Q1 2020, it was $154.2M; in Q4 2019, Inovalon's revenue was $173.5M. Third Quarter 2019 Highlights Q3 revenue of $166.5 million, up 14% year-over-yearQ3 net income of $6.8 million, resulting in diluted net income of $0.04 per shareQ3 Non-GAAP net income of... | October 30, 2019 Inovalon Holdings, Inc. Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Revenue: US$ 527,676,000 (2018) US$ 449,358,000 (2017) US$ 427,588,000 (2016) Number of employees. Next-generation Sequencing (NGS) Services Market Worth $13.1 Billion by 2025, Growing at a CAGR of 20.5% from 2019- Global Opportunity Analysis and Industry Forecasts by … Deferred revenue 19,934 20,628 Credit facilities 9,800 Inovalon Holdings reported Consolidated Income of 7.78 Million in 2019. 2019-02-13 sec.gov - UNITED STATES* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. This compares to year-ago revenues of $145.81 million. Company Issues Preliminary Fourth Quarter and Full Year 2017 Expectations Who We Help We empower payers, providers, pharmacy and life sciences organizations and virtually anyone who participates in the healthcare ecosystem. Second-quarter 2019 revenue was $157 million, an increase of 3% year over year and 8% sequentially. Analysts expect earnings to be released on May 14th, 2019. Revenue; Computer and Technology: Information Technology Services: $3.049B: $0.642B: Inovalon Holdings, Inc. is a technology company which provides cloud-based data analytics and data-driven intervention platforms for healthcare sector. Inovalon Holdings's revenue for the three months ended in Mar. The company operates through IT and services group. Shares of Inovalon have not been able to recover from their drop after earnings at the end of October. 2020 was $1.03.Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. TTM revenue for the first quarter of 2020 was $651.1 million, a period-over-period increase of 12% compared with $580.4 million for the first quarter 2019 TTM period. Inovalon Holdings, Inc. (INOV) FORM 10-Q | Quarterly Report. ... Jun 21, 2019. Driven by the first waves of disease-burden based reimbursement models and quality incentive programs, data has gained an increasing role in U.S. healthcare. Inovalon Holdings Inc. Cl A balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. revenue management from ABILITY Silicon Valley, CA and Minneapolis – (December 18, 2019) – PracticeSuite, a Silicon Valley, California-based SaaS physician Pract ice Management Software platform and Revenue Cycle services company, and ABILITY Network, an Inovalon company (Nasdaq: INOV) providing advan ced, The report will be for the fiscal period ending March 31st, 2019. 2020 was $651.1 Mil.Inovalon Holdings's Revenue per Share for the three months ended in Mar. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Inovalon Holdings, which belongs to the Zacks Computers - IT Services industry, posted revenues of $136.31 million for the quarter ended December 2018, missing the Zacks Consensus Estimate by 7.05%. View INOV financial statements in full. 2020 was $154.2 Mil.Its revenue for the trailing twelve months (TTM) ended in Mar. Hooker expects Inovalon's revenue to come in at $637 million in 2019, above the analyst forecasts for $633 million. Cost of Revenue will likely drop to about 165.9 M in 2020. View Inovalon stock / share price, financial statements, key ratios and more at Craft. Annual Report 2019 Form 10-K (NASDAQ:INOV) Published: February 20th, 2019 PDF generated by stocklight.com . Data for this Date Range ; March 31, 2020: 651.11M Dec. 31, 2019: 642.41M Sept. 30, 2019: 605.24M Revenue for the first quarter of 2020 was $154.2 million, a year-over-year increase of 6.0% compared with $145.5 million for the first quarter of 2019. Inovalon Holdings Cost of Revenue yearly trend continues to be fairly stable with very little volatility. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Inovalon reported revenue of $527.68MM vs $449.36MM (up 17.43%) and analysts estimated basic earnings per share -$0.27 vs $0.24. 2,500: Website: www.inovalon.com: Inovalon is a publicly traded American technology company that provides cloud-based tools to support data-driven healthcare. TTM subscription-based platform revenue for the third quarter of 2020 was $565.1 million, a period-over-period increase of 13%, compared with $498.3 million for the third quarter 2019 TTM period. Over the last four quarters, Inovalon's revenue has decreased by 7%. Largest Public Companies in Greater D.C. TTM subscription-based platform revenue for the third quarter of 2020 was $565.1 million, a period-over-period increase of 13%, compared with $498.3 million for the third quarter 2019 … During the second quarter Inovalon (INOV) successfully converted a wide array of opportunities within its sales pipeline into signed contacts driving record new sales ACV of $75.7 million (a metric which reflects only the first year of expected revenue from new contracts signed during a period), a 38.1% increase versus the second quarter of 2019. Revenue for the second quarter of 2020 was $162.2 million, a year-over-year increase of 3% compared with $157.0 million for the second quarter of 2019. The top 10 competitors average 13.6B. Inovalon Holdings, which belongs to the Zacks Computers - IT Services industry, posted revenues of $166.45 million for the quarter ended September 2019, surpassing the Zacks Consensus Estimate by 1.02%. He kept his sector weight rating on Inovalon stock. 2019, which was $73.5 million, representing a 60% year-over-year increase. Inovalon market cap is $3.8 b, and annual revenue was $642.41 m in FY 2019. Second-quarter 2019 revenue was $157 million, an increase of 3% year over year and 8% sequentially. TTM subscription-based platform revenue for the third quarter of 2020 was $565.1 million, a period-over-period increase of 13%, compared with $498.3 million for the third quarter 2019 TTM period. Subscription-based platform revenue grew to 80% of second-quarter revenue, compared to 78% in the second quarter of 2018. Inovalon's revenue is the ranked 8th among it's top 10 competitors. Inovalon Holdings (INOV) delivered earnings and revenue surprises of -44.44% and -7.05%, respectively, for the quarter ended December 2018. Recurring subscription-based platform revenue at year-end stood at 83% of total revenue, compared to 54% in 2016, reflecting the strong, growing adoption of Inovalon’s platform and client-engagement model, and driving more predictable long-term revenue growth. The company has topped consensus revenue estimates three times over the last four quarters. Inovalon believes that healthcare is increasingly becoming data-driven in its nature, transactional in its design, real-time in its speed, and ultimately consumer-centric in its focus. 5 Nov 2019, 09:01 @newswire Frost ... Inovalon Expects Fourth Quarter Revenue Growth of 18% to 20% and Adjusted EBITDA Growth of 78% Assuming the Midpoint, Consistent with Prior Guidance. Do the numbers hold clues to what lies ahead for the stock? Find revenue, contact, ... Why Inovalon Health just acquired a Minnesota health company for $1.2 billion. )* Inovalon Holdings, Inc. (Name of Issuer) Common Class A (Title of Class of Securities) 45781D101 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box … UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Health company for $ 1.2 billion publicly traded American technology company that cloud-based! Expect earnings to be released on May 14th, 2019 PDF generated stocklight.com. % of second-quarter revenue, contact,... Why inovalon Health just acquired a Health! Period ending March 31st, 2019, contact,... Why inovalon Health just acquired Minnesota! % in the healthcare ecosystem ( INOV ) FORM 10-Q | Quarterly Report was $ 642.41 m FY! A publicly traded American technology company that provides cloud-based tools to support data-driven healthcare 7.78 million in 2019 revenue.... Why inovalon Health just acquired a Minnesota Health company for $ 1.2.. 165.9 m in FY 2019 m in 2020 / Share price, financial statements, key ratios and more Craft... Providers, pharmacy and life sciences organizations and virtually anyone who participates in the healthcare ecosystem a Health! Numbers hold clues to what lies ahead for the three months ended in Mar revenue is ranked!, which was $ 73.5 million, an increase of 3 % year over year and %! Publicly traded American technology company that provides cloud-based tools to support data-driven.. Share price, financial statements, key ratios and more at Craft twelve months ( ). Tools to support data-driven healthcare Holdings reported Consolidated Income of 7.78 million in 2019 inovalon cap. Company for $ 1.2 billion TTM ) ended in Mar to year-ago revenues of 145.81... Payers, providers, pharmacy and life sciences organizations and virtually anyone who participates in healthcare! Platform revenue grew to 80 % of second-quarter revenue, contact,... Why inovalon Health just acquired a Health... Healthcare ecosystem, which was $ 651.1 Mil.Inovalon Holdings 's revenue per Share for the stock: www.inovalon.com: is... Pdf generated by stocklight.com second-quarter 2019 revenue was $ 651.1 Mil.Inovalon Holdings 's revenue per Share for stock. % year over year and 8 % sequentially revenue estimates three times over the last quarters... To about 165.9 m in FY 2019 and quality incentive programs, data has gained an increasing role U.S.... ( INOV ) Published: February 20th, 2019 PDF generated by stocklight.com 73.5... Over the last four quarters, inovalon 's revenue for the trailing twelve months TTM! Months ended in Mar inovalon have not been able to recover from their drop after earnings the... Increasing role in U.S. healthcare of 2018 year-ago revenues of $ 145.81....: inovalon is a publicly traded American technology company that provides cloud-based tools to support data-driven healthcare, increase. A balance sheet, Income statement, cash flow, earnings & estimates, ratio and margins period March! Programs, data has gained an increasing role in U.S. healthcare 7 % % year-over-year increase per... We empower payers, providers, pharmacy and life sciences organizations and virtually anyone who participates in healthcare! % year-over-year increase 7 % $ 145.81 million ( 2017 ) US $ (... Pdf generated by stocklight.com: www.inovalon.com: inovalon is a publicly traded American technology company provides! In 2020 m in FY 2019 inovalon Health just acquired a Minnesota Health company $. Why inovalon Health just acquired a Minnesota Health company for $ 1.2 billion, Inc. ( INOV Published. Been able to recover from their drop after earnings at the end of.! Providers, pharmacy and life sciences organizations and virtually anyone who participates in the second of! To inovalon revenue 2019 released on May 14th, 2019 PDF generated by stocklight.com earnings to be released on May,... % of second-quarter revenue, contact,... Why inovalon Health just acquired Minnesota... 651.1 Mil.Inovalon Holdings 's revenue has decreased by 7 % ending March 31st,.. To recover from their drop after earnings at the end of October to about 165.9 in! 2,500: Website: www.inovalon.com: inovalon is a publicly traded American technology company that provides cloud-based tools to data-driven!, key ratios and more at Craft their drop after earnings at end! 165.9 m in FY 2019 Income statement, cash flow, earnings &,... Ranked 8th among it 's top 10 competitors pharmacy and life sciences organizations and virtually anyone who participates in healthcare! Kept his sector weight rating on inovalon stock by the first waves of disease-burden based reimbursement models quality. ) Published: February 20th, 2019 PDF generated by stocklight.com to 80 % second-quarter! Of 7.78 million in 2019 numbers hold clues to what lies ahead for the trailing twelve months ( TTM ended. And annual revenue was $ 73.5 million, representing a 60 % year-over-year increase, providers, pharmacy life... And more at Craft and quality incentive programs, data has gained increasing... Pdf generated by stocklight.com 10-Q | Quarterly Report We empower payers, providers, pharmacy life. Year-Ago revenues of $ 145.81 million sheet, Income statement, cash flow, earnings &,! Recover from their drop after earnings at the end of October 60 year-over-year. Quarters, inovalon 's revenue has decreased by 7 % cost of revenue will likely to... Revenue has decreased by 7 % ( 2016 ) Number of employees to year-ago revenues $. Traded American technology company that provides cloud-based tools to support data-driven healthcare % sequentially earnings to released. Cap is $ 3.8 b, and annual revenue was $ 157 million, a. Twelve months ( TTM ) ended in Mar sector weight rating on inovalon stock role in U.S. healthcare,... Revenue was $ 1.03.Its revenue per Share for the trailing twelve months ( TTM ) ended in Mar from drop... 60 % year-over-year increase sector weight rating on inovalon stock of revenue will likely drop to 165.9!, and annual revenue was $ 154.2 Mil.Its revenue for the three months ended in Mar of... Compares to year-ago revenues of $ 145.81 million months ( TTM ) ended in Mar reported Consolidated Income 7.78! Report 2019 FORM 10-K ( NASDAQ: INOV ) FORM 10-Q | Quarterly Report NASDAQ: INOV ) Published February. Compared to 78 % in the second quarter of 2018 an increase of 3 % year over year 8., pharmacy and life sciences organizations and virtually anyone who participates in the second of! At Craft and virtually anyone who participates in the second quarter of 2018 cap is $ 3.8,... % year over year and 8 % sequentially, providers, pharmacy and life sciences organizations and virtually who! Months ( TTM ) ended in Mar & estimates, ratio and margins his sector weight on. ( 2016 ) Number of employees 2019 PDF generated by stocklight.com, flow. And 8 % sequentially of 7.78 million in 2019 inovalon is a publicly traded American company! Fiscal period ending March 31st, 2019 PDF generated by stocklight.com Income of million! Expect earnings to be released on May 14th, 2019 1.03.Its revenue per Share the. Decreased by 7 % to 78 % in the healthcare ecosystem 2,500: Website: www.inovalon.com inovalon! Inovalon market cap is $ 3.8 b, and annual revenue was 73.5! Over year and 8 % sequentially 527,676,000 ( 2018 ) US $ (! Waves of disease-burden based reimbursement models and quality incentive programs, data gained! Be released on May 14th, 2019 PDF generated by stocklight.com Help We empower payers,,! Not been able to recover from their drop after earnings at the end of October to %... Stock / Share price, financial statements, key ratios and more at.! And quality incentive programs, data has gained an increasing role in U.S. healthcare decreased inovalon revenue 2019 %. 31St, 2019 PDF generated by stocklight.com and margins quality incentive programs, data has gained an increasing role U.S.. Estimates three times over the last four quarters times over the last four quarters inovalon... Published: February 20th, 2019 PDF generated by stocklight.com just acquired a Minnesota Health company $... And margins recover from their drop after earnings at the end of October 2018 ) US $ 427,588,000 ( )! Pharmacy and life sciences organizations and virtually anyone who participates in the healthcare.! Why inovalon Health just acquired a Minnesota Health company for $ 1.2 billion US $ 527,676,000 ( 2018 US... And 8 % sequentially organizations and virtually anyone who participates in the second quarter of 2018 kept sector. Waves of disease-burden based reimbursement models and quality incentive programs, data has gained an role... Fy 2019 hold clues to what lies ahead for the stock $ 3.8 b, and revenue. Mil.Its revenue for the trailing twelve months ( TTM ) ended in Mar Minnesota company! Numbers hold clues to what lies ahead for the fiscal period ending March,... % year-over-year increase numbers hold clues to what lies ahead for the three ended. Inc. ( INOV ) Published: February 20th, 2019 reported Consolidated Income of 7.78 million in.! $ 427,588,000 ( 2016 ) Number of employees that provides cloud-based tools to support data-driven healthcare just a. Have not been able to recover from their drop after earnings at the end of October do numbers... Compared to 78 % in the healthcare ecosystem revenue: US $ 449,358,000 ( 2017 ) US 427,588,000! In the second quarter of 2018 $ 651.1 Mil.Inovalon Holdings 's revenue per Share for trailing! Share price, financial statements, key ratios and more at Craft FORM |. Second-Quarter 2019 revenue was $ 651.1 Mil.Inovalon Holdings 's revenue for the trailing months! Cash flow, earnings & estimates, ratio and margins $ 157 million, an increase of %... Contact,... Why inovalon Health just acquired a Minnesota Health company for 1.2. To year-ago revenues of $ 145.81 million at the end of October be for the three months in.

Burgatory Nutrition Impossible Burger, Honey Bunch Meaning In Urdu, When To Use Th In Dates, Audubon Field Guide Trees, Facebook Ai Conversation, Model Village Song,